PR NEWS Logo
Home
PR NewsWire
NewsWire Today
MarketWire
Submit Your Feeds
Business News
•
MarketWire
• Versartis Presents Data at EASD for New Diabetes Drug VRS-859 (Exenatide-XTEN)
Versartis Presents Data at EASD for New Diabetes Drug VRS-859 (Exenatide-XTEN)
Versartis Presents Data at EASD for New Diabetes Drug VRS-859 (Exenatide-XTEN)
Type 2 Diabetes Mellitus Drug for Monthly Dosing Currently in Phase I Study
View More :
http://www.marketwire.com/mw/release.do?id=1322082&sourceType=3
Releted News by marketwire
Versartis Presents Data at EASD for New Diabetes Drug VRS-859 (Exenatide-XTEN)